Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

FIVP responds to CMA working papers
FIVP has supported calls for more transparency in the sector.
The group called for decisions to address ‘unique challenges’ faced by independents.

The Federation of Independent Veterinary Practices (FIVP) has submitted its formal response to working papers released by the Competition and Markets Authority (CMA) in February 2025.

The not-for-profit organisation, which has been a major party in the investigation, called for future recommendations to consider independent practices, ensuring a ‘level playing field’ across the sector.

In its response, FIVP commends the ‘thorough and rigorous’ response submitted by the British Veterinary Association earlier this week. However, it also raises further observations on how proposed recommendations might affect independent practices.

FIVP has expressed its support of the CMA’s proposed action to improve transparency and informed decision-making.

It reported that independent practices were dedicated to providing ‘high-quality, personalised care’ to their clients. The response highlights continuous efforts from its members to improve the information and services available to owners.

FIVP says that it is an advocate for measures which advance business transparency, including pricing and ownership, and protect the interests of pet owners.

However, FIVP has also highlighted the ‘unique challenges’ and ‘competitive disparities’ it believes the reports have brought to light. It maintains that it is only in a ‘fair and competitive market’ which independent practices will remain sustainable and able to provide reliable pet care to clients.

Among the measures which the organisation believes will benefit the veterinary sector is a review of regulatory frameworks. This includes a review of the Veterinary Surgeons Act 1966, which FIVP has supported since the launch of the inquiry.

In conclusion, FIVP has emphasised the importance of a level playing field to maintain a ‘diverse and competitive’ veterinary market. It maintains its advocacy of measures which support the sustainability and growth of independent practices.

Rita Dingwall, chairperson for FIVP, said: “FIVP values the opportunity to participate in the CMA submissions process as it allows us to contribute to the advancement of veterinary care standards and the improvement of clients’ experiences at vet practices.

“We hope that the CMA’s upcoming provisional decision will take into account the unique challenges faced by independent practices and contribute to a veterinary sector which is fair for all business models.”

FIVP’s full response to the CMA inquiry is available here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.